HMOX1 and atrial fibrillation: The beneficial effect of AF was dose‐dependent, and the activation of the nuclear erythroid‐related factor 2 (Nrf2)/heme oxygenase‐1 (HO‐1) pathway might contribute to the therapeutic effect.